Who can use Quviviq(Daridorexant)?
Daridorexant (Quviviq) is an orexin receptor antagonist indicated for the treatment of adults with insomnia characterized by difficulty initiating and/or maintaining sleep.
Daridorexant (Quviviq) is an orexin receptor antagonist indicated for the treatment of adults with insomnia characterized by difficulty initiating and/or maintaining sleep.
Quviviq is a new generation of insomnia treatment drugs, and its unique pharmacological effects provide a new...
Quviviq is a novel dual orexin receptor antagonist that was approved by the US FDA in 2022 for the treatment of...
